David R. Guyer

Chief Executive Officer, IVERIC bio.

Companies

EyePoint PharmaceuticalsBoard member Jan 29, 2019 to Jul 16, 2024¹
IVERIC bioChair Jul 5, 2017 to Dec 22, 2020²
IVERIC bioBoard member Sep 24, 2013 to Feb 1, 2017³
IVERIC bioChief executive officer Sep 24, 2013 to Feb 1, 2017³
Applied Genetic Technologies CorporationBoard member Jul 7, 2014 to Jul 7, 2014⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 12, 2024Sold 11,625 shares at $10.06 of EyePoint Pharmaceuticals⁵
Jul 12, 2024Exercised options 6,525 shares at $3.26 of EyePoint Pharmaceuticals⁵
Jul 12, 2024Exercised options 3,250 shares at $3.50 of EyePoint Pharmaceuticals⁵
Jun 3, 2024Sold 11,625 shares at $10.30 of EyePoint Pharmaceuticals⁶
Jun 3, 2024Exercised options 3,250 shares at $3.50 of EyePoint Pharmaceuticals⁶
Jun 3, 2024Exercised options 6,525 shares at $3.26 of EyePoint Pharmaceuticals⁶
May 14, 2024Sold 11,625 shares at $12.65 of EyePoint Pharmaceuticals⁷
May 14, 2024Exercised options 3,250 shares at $3.50 of EyePoint Pharmaceuticals⁷
May 14, 2024Exercised options 6,525 shares at $3.26 of EyePoint Pharmaceuticals⁷
Feb 9, 2023Exercised options 3,000 shares of EyePoint Pharmaceuticals⁸
Feb 9, 2022Exercised options 2,500 shares of EyePoint Pharmaceuticals⁹

The numbers on this page point here. Each one links to the record it came from.